iXCells Biotechnologies Selected to Perform the First Pilot in Patient-Led ALS Precision Medicine Effort

The lab will run the inaugural study for Project Mosaic, a groundbreaking initiative to develop patient-specific models of sporadic ALS and fix a pipeline where 99% of treatments fail